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Grand Challenge #1 (Energy & Sustainability): Urgent need for oil replacement
 Use renewable feedstocks to produce fuels, chemicals, and drugs





• Type III PKS
• N-Oxygenases
Modeling
#1. Engineering Microbial Factories

























Metabolic Engineering Research Lab 












Overall Goal: Develop and apply systems and synthetic biology approaches to 
engineer microorganisms capable of cost-effectively producing industrial 























Technology U.S. Factory Sales of Solid State Products 
Microelectronics and Biotechnology




























“Read out the genetic code”
First product: human insulin, produced in E. coli in 1978.
- Recombinant human growth hormone 
- Recombinant blood clotting factor VIII
- ……
Global market size for recombinant proteins: ~$60B in 2009
human insulin
Transformative Advances in 
DNA Sequencing and Synthesis
Carlson, Nat. Biotech. 27, 1091 (2009)
Carr and Church, Nat. Biotech. 27, 1151 (2009)
?10-1000’s genescomplex chemicals and materialsorganisms as products 
...
Building Large DNA Molecules via 
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Eight-gene Pathway: A Combined 











Broad Application of DNA Assembler
Pathway Engineering
Pathway Discovery Synthetic Biology








Wen et al. Current Opinion in Biotech. (2009)
Gibson et al. PNAS
Online publication date: Dec. 10, 2008
Shao et al. Nucleic Acids Res. 
Online publication date: Dec. 12, 2008
Discovering New Drugs
Activating Cryptic Pathways from 
Sequenced Genomes and Metagenomes
News & Views: 
Cobb and Zhao, Nature Biotech 2012
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Pentose Utilization in Yeast





Glucose Repression in Mixed 
Sugar Fermentation
 Glucose repression occurs in S. cerevisiae
 Alternative carbon source fermentation is inhibited in the presence 
of glucose
 Lag time in xylose and arabinose consumption curve
















 Cellodextrin transport system from Neurospora crassa
 Cellodextrin transporters: NCU00801 (cdt1), NCU00809, NCU08114(cdt2)
 β-glucosidase: NCU00130 (gh1-1)
Galazka JM, et al. Science 330, 84 (2010)
 S. cerevisiae with a heterologous cellodextrin transport system showed 




 3 transporters: cdt-1, cdt-2, 
NCU00809
 2 β-glucosidases: 
gh1-1 from N. crassa, 












 Use DNA assembler method 
to integrate genes into 
pRS425 plasmid
 Strains
 6 plasmids constructed were 
transformed into S. cerevisiae
















Yield ethanol 0.28 0.22
Productivity ethanol  (g/(L h)) 0.23 0.07
cellobiose (■) , xylose  (▲), glucose(●), ethanol (▼) , Dry cell weight (□)
Mixed Sugar Cultivation in 
Bioreactor: Cellobiose+Xylose
SL01 SL00
cellobiose (■) , xylose  (▲), glucose(●), ethanol (▼) , Dry cell weight (□)
SL01 SL00
Yield ethanol 0.39 0.24
Productivity ethanol  (g/(L h)) 0.49 0.09
Li et al. Mol Biosyst 2010
Balancing Metabolic Flux Remains a 
Big Challenge
 Production of value-added compounds usually requires introduction of 
multi-step metabolic pathways
 Metabolic flux in multistep metabolic pathways need to be optimized to 
avoid metabolic burden 
 Overexpression of certain genes, 
 Redox imbalance from unmatched cofactor specificity
 Accumulation of unstable or toxic intermediates
 Traditional approaches
 Overexpression and deletion of certain genes in metabolic pathways
 Modulating the expression levels of individual enzymes
 Protein engineering to improve performance of rate limiting enzymes
 Targeting a specific enzyme instead of the overall pathway
 Simultaneous optimization of multiple metabolic genes remains a big 
challenge
Balancing Metabolic Flux Remains a 
Big Challenge
 Perturbation of global transcription machinery
 Genome-scale mapping of fitness altering genes
 Multiplex genome engineering
 Balance metabolic flux within the target pathway
 Strengths of promoters
 Ribosome binding sites
Intergenic regions
 Synthetic scaffolds
Pfleger et al.,Nat Biotechnol 24, 1027-1032 (2006)
Dueber et al., Nat Biotechnol 27, 753-759 (2009)
Alper et al.,  Metab Eng 9, 258-267 (2007)
Warnecke et al., Metab Eng 12, 241-250 (2010)
Warner et al., Nature Biotechnology 28, 856-U138 (2010)
Wang et al., Nature 460, 894-898 (2009)
Salis et al.,  Nat Biotechnol 27, 946-950 (2009)
Alper et al., Proc Natl Acad Sci U S A 102, 12678-12683 (2005)
Pathway Optimization 
by COMPACTER
Customized Optimization of Metabolic Pathways by Combinatorial 
Transcriptional Engineering (COMPACTER)
Target pathway
Gene3 Terminator3Gene2 Terminator2Gene1 Terminator1Promoter1 Promoter2 Promoter3
Promoter1
Promoter1
Screening/selection of mutant pathways with desired phenotype







 Selected 6 yeast promoters
 Nucleotide analogue mutagenesis
 Isolating promoter mutants via FACS
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Alper et al. PNAS 102, 12678-12683 (2005)
Sun et al. B&B, 2012

































































































Xylose Utilizing Pathway Cellobiose Utilizing Pathway
 Host strain: INVSc1 (Invitrogen)
 Diploid, auxotrophic mutation available
 Control
 pRS416-PDC1p(WT)-csXR-TEF1p(WT)-ctXDH-ENO2p(WT)-ppXKS
 Backbone: pRS416 
 Single copy shuttle vector

























































Optimization of the Xylose Utilizing 
Pathway in the INVSc1 Strain
 Initial OD~1









Ethanol yield 0.16 0.25
g/g 

































































Optimization of the Xylose Utilizing 
Pathway in an Industrial Strain
 Host Strain




 Single copy shuttle vector




























































 Oxygen limited condition
 YP media
YPD seed YPX seed
Unit








0 0.17 0.24 g/L/hr
Ethanol yield 0 0.24 0.26 g/g xylose
xylose (■), ethanol (▼) 
































































 Switching optimized xylose utilizing pathways 





















































































































xylose (■), ethanol (▼) 




































































































































 qPCR analysis of the optimized xylose utilizing pathways 
between laboratory and industrial strains

Optimization of the Cellobiose
Utilizing Pathway
Optimized Xylose Utilizing 
Pathways are Strain Specific
Open symbol: pathway optimized in INVSc1 strain, Solid symbol: pathway optimized in Classic 
strain, Red circle: cellobiose, Black square: OD (A600), Blue down triangle: ethanol. 
Optimized Cellobiose Utilizing 
Pathways are Strain Specific
 qPCR analysis of the optimized cellobiose utilizing 
pathways between laboratory and industrial strains
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 #9,#91 and #9118 have same 
final OD, ethanol 
concentration and glucose 
accumulation
 A#9118 has lower OD and 
higher ethanol 
 A#9118 has much lower 
glucose accumulation
 No mutations were found in 
promoter regions in A#9118
Directed Evolution for Strain 
Development
Cellobiose fermentation performance of evolved yeast 


























L. Lynd et al. Curr Opin Biotechnol 577 (2005)











 Yeast surface display of functional minicellulosomes
 Functional display of a mini-scaffoldin
 Successful assembly of minicellulosomes through 
cohesin-dockerin interaction
 Synergistic hydrolysis of cellulose
 Direct fermentation of hydrolysate (glucose) to ethanol












































Ethanol production Residual PASC
Wen, F., Sun, J. and Zhao, H. AEM (2010)
Yield: 0.31 grams of ethanol per gram of PASC
62% of theoretical yield











































Direct Conversion of Xylan to Ethanol 
by Engineered Hemicellulosomes
Sun, J. et al. AEM (2012)





 HZ3345: Ethanol    HZ3345: Residual total sugar













































Sun, J. et al. AEM (2012)

















































Yield: 0.31 grams of ethanol per gram of 
birchwood xylan
Summary
• Developed a DNA assembler method for constructing large 
DNA molecules such as pathways, plasmids, and genomes. 
• Developed a DNA assembler based synthetic biology method 
(COMPACTER) for optimizing the metabolic flux in a 
heterologous pathway
• Engineered a yeast strain capable of simultaneously and 
efficiently utilizing C5/C6 sugars
• Engineered yeast strains for consolidated bioprocessing of 
cellulose and xylan respectively. 
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Mark your calendars
For ECI’s Biochemical and Molecular 
Engineering Conference to be held in 
Beijing, China
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